with a single cell.™
An early cloned blastocyst.
LA JOLLA, CA – Earlier this year, Stemagen, a privately held embryonic stem cell research company, announced it has become the first in the world to create, and meticulously document, a cloned human embryo using somatic cell nuclear transfer (SCNT).
Stemagen CEO Samuel H. Wood, M.D., Ph.D., a co-author of the publication and a donor of the cells from which the embryos were cloned, terms this achievement “a critical milestone in the development of patient-specific embryonic stem cells for human therapeutic use, potentially including developing treatments for Parkinson’s, Alzheimer’s and other degenerative diseases.” Stemagen’s research is exhaustively detailed in a paper published in the January issue of the highly regarded peer-reviewed scientific journal Stem Cells.
Dr. Samuel H. Wood, CEO of Stemagen, made strong statements against human reproductive cloning in an interview with CNN’s “Lou Dobbs Tonight” on April 24, 2009. In the interview Dr. Wood called the attempts by Dr. Panayiotis Zavos’ attempts to reproductively clone humans, featured in a recent BBC Documentary, “dangerous” and “highly unethical”. For more on the interview, visit: http://loudobbs.tv.cnn.com/ |
|
858•453•2305 ~ f 858•225•0376 ~ info@stemagen.com ~ La Jolla, California |